Khalid Al‐Naamani

2.1k total citations
39 papers, 346 citations indexed

About

Khalid Al‐Naamani is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Khalid Al‐Naamani has authored 39 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 19 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Khalid Al‐Naamani's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (12 papers). Khalid Al‐Naamani is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (12 papers). Khalid Al‐Naamani collaborates with scholars based in Oman, Egypt and Saudi Arabia. Khalid Al‐Naamani's co-authors include Siham Al‐Sinani, Alan Barkun, Adhra Al‐Mawali, Tarek Hijal, Thao Huynh, Tam Nguyen, Viviane Nguyen, Elias A. Said, Ibrahim Al‐Zakwani and Mohammed S. Al‐Balushi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Digestive Diseases and Sciences.

In The Last Decade

Khalid Al‐Naamani

30 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Al‐Naamani Oman 10 105 86 71 64 49 39 346
Mazen M. Jamal United States 10 180 1.7× 70 0.8× 156 2.2× 164 2.6× 35 0.7× 18 487
M. Antivalle Italy 12 78 0.7× 67 0.8× 29 0.4× 18 0.3× 29 0.6× 30 489
Laura Tribus Romania 13 220 2.1× 76 0.9× 131 1.8× 116 1.8× 19 0.4× 57 502
Ji Min Lee South Korea 13 173 1.6× 49 0.6× 191 2.7× 32 0.5× 11 0.2× 60 453
T. Murphy Goodwin United States 10 76 0.7× 73 0.8× 109 1.5× 17 0.3× 22 0.4× 18 554
Fatih Aslan Türkiye 13 117 1.1× 173 2.0× 155 2.2× 29 0.5× 30 0.6× 51 440
Д. И. Абдулганиева Russia 8 51 0.5× 18 0.2× 36 0.5× 24 0.4× 7 0.1× 68 247
Pankti Mehta India 10 135 1.3× 30 0.3× 45 0.6× 21 0.3× 6 0.1× 47 333
Emrah Alper Türkiye 13 102 1.0× 187 2.2× 242 3.4× 29 0.5× 13 0.3× 59 491
Francisco Arnal Spain 12 82 0.8× 66 0.8× 297 4.2× 199 3.1× 42 0.9× 26 448

Countries citing papers authored by Khalid Al‐Naamani

Since Specialization
Citations

This map shows the geographic impact of Khalid Al‐Naamani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Al‐Naamani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Al‐Naamani more than expected).

Fields of papers citing papers by Khalid Al‐Naamani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Al‐Naamani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Al‐Naamani. The network helps show where Khalid Al‐Naamani may publish in the future.

Co-authorship network of co-authors of Khalid Al‐Naamani

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Al‐Naamani. A scholar is included among the top collaborators of Khalid Al‐Naamani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Al‐Naamani. Khalid Al‐Naamani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Balushi, Mohammed S., Crystal Y. Koh, Khalid Al‐Naamani, et al.. (2025). HLA-B*58 and HLA-C*2 Alleles Are Associated with the Occurrence of Rheumatoid Arthritis Among Omanis. Journal of Clinical Medicine. 14(4). 1219–1219.
2.
El‐Kassas, Mohamed, Marcela Villota‐Rivas, Khalid Alswat, et al.. (2025). Metabolic Dysfunction‐Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda. Liver International. 45(6). e70108–e70108. 2 indexed citations
3.
El‐Kassas, Mohamed, Khalid Alswat, Asma Labidi, et al.. (2025). Frailty and MASLD in the Arab region: An urgent call for regional clinical and public health strategies. Arab Journal of Gastroenterology. 26(4). 315–317.
4.
Al‐Naamani, Khalid, et al.. (2025). Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing. Journal of Viral Hepatitis. 32(10). e70072–e70072.
5.
Pan, Ziyan, Khalid Al‐Naamani, Moutaz Derbala, et al.. (2025). Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990–2021. Annals of Hepatology. 30(2). 102104–102104.
6.
Elbaz, Tamer, Khalid Al‐Naamani, Hazem Abosheaishaa, Khalid Alswat, & Mohamed El‐Kassas. (2025). Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in Egypt. Journal of Viral Hepatitis. 32(7). e70032–e70032.
7.
Al‐Naamani, Khalid, et al.. (2025). Proton Pump Inhibitor Use and Risk of Dementia: An Umbrella Review of Systematic Reviews and Meta-Analyses. Digestive Diseases and Sciences. 71(3). 1029–1040.
8.
9.
Said, Elias A., Mohammed S. Al‐Balushi, Murtadha Al‐Khabori, et al.. (2023). Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs. Journal of Immunology Research. 2023. 1–13. 1 indexed citations
10.
Said, Elias A., Mohammed S. Al‐Balushi, Murtadha Al‐Khabori, et al.. (2022). Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production. PLoS ONE. 17(4). e0267662–e0267662. 4 indexed citations
11.
Al‐Naamani, Khalid, et al.. (2021). Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman. Journal of Infection and Public Health. 14(11). 1578–1584. 5 indexed citations
12.
Al‐Busafi, Said A., et al.. (2021). Risk Factors for Hepatitis B Virus Transmission in Oman. Oman Medical Journal. 36(4). e287–e287. 5 indexed citations
13.
Al‐Naamani, Khalid, et al.. (2021). The Post-acute COVID-19 Syndrome (Long COVID). Oman Medical Journal. 36(1). e220–e220. 41 indexed citations
14.
Al‐Naamani, Khalid, et al.. (2021). Hepatitis B Related Liver Cirrhosis in Oman. Oman Medical Journal. 37(3). e384–e384. 1 indexed citations
15.
Al‐Naamani, Khalid, Bassim Al Bahrani, Siham Al‐Sinani, et al.. (2020). Hepatocellular Carcinoma in Oman: An analysis of 284 cases. Sultan Qaboos University medical journal. 20(3). e316–322. 2 indexed citations
16.
Said, Elias A., Khalid Al‐Naamani, Mohammed S. Al‐Balushi, et al.. (2016). A Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression. PLoS ONE. 11(4). e0153191–e0153191. 6 indexed citations
17.
Said, Elias A., Khalid Al‐Naamani, Mohammed S. Al‐Balushi, et al.. (2016). Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection. PLoS ONE. 11(6). e0158265–e0158265. 27 indexed citations
18.
Al‐Naamani, Khalid, et al.. (2013). Characteristics of Hepatitis B Infection in a Sample of Omani Patients = خصائص إلتهاب الكبد الوبائي ب في عينة من المرضى العمانيين. Sultan Qaboos University medical journal. 13(3). 380–385. 7 indexed citations
19.
Al‐Sinani, Siham, et al.. (2013). Prevalence of Celiac Disease in Omani Children with Type 1 Diabetes Mellitus: A Cross Sectional Study. Oman Medical Journal. 28(4). 260–263. 18 indexed citations
20.
Al‐Naamani, Khalid, et al.. (2007). Predictive values of the electrocardiogram in diagnosing pulmonary hypertension. International Journal of Cardiology. 127(2). 214–218. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mazen M. Jamal Breakdown of academic impact, for papers by M. Antivalle Breakdown of academic impact, for papers by Laura Tribus Breakdown of academic impact, for papers by Ji Min Lee Breakdown of academic impact, for papers by T. Murphy Goodwin Breakdown of academic impact, for papers by Fatih Aslan Breakdown of academic impact, for papers by Д. И. Абдулганиева Breakdown of academic impact, for papers by Pankti Mehta Breakdown of academic impact, for papers by Emrah Alper Breakdown of academic impact, for papers by Francisco Arnal
Rankless by CCL
2026